The landscape of HIV treatment has evolved significantly over the years, providing patients with innovative options that improve their quality of life and manage the virus more effectively. Among these advancements are two notable medications: Biktarvy and Symtuza. Both of these antiretroviral therapies have garnered attention for their efficacy and once-daily dosing regimens, which can enhance adherence and convenience for patients. As individuals and healthcare providers navigate the complexities of HIV treatment, understanding the differences and similarities between these medications becomes paramount. While both Biktarvy and Symtuza are designed to combat HIV, they possess distinct pharmacological profiles, side effects, and mechanisms of action that can influence a patient’s treatment journey.…